Fragasso Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $530K | Sell |
22,006
-780
| -3% | -$20.4K | 0.03% | 213 |
|
|
2026
Q1 | $634K | Sell |
22,786
-470
| -2% | -$12.5K | 0.04% | 177 |
|
|
2025
Q4 | $579K | Buy |
23,256
+2
| +0% | +$50 | 0.04% | 184 |
|
|
2025
Q3 | $636K | Buy |
23,254
+794
| +4% | +$19.6K | 0.04% | 164 |
|
|
2025
Q2 | $544K | Buy |
22,460
+480
| +2% | +$11.2K | 0.04% | 179 |
|
|
2025
Q1 | $557K | Sell |
21,980
-1,010
| -4% | -$26.4K | 0.04% | 164 |
|
|
2024
Q4 | $610K | Buy |
22,990
+286
| +1% | +$7.76K | 0.05% | 152 |
|
|
2024
Q3 | $657K | Sell |
22,704
-6,640
| -23% | -$194K | 0.05% | 148 |
|
|
2024
Q2 | $821K | Sell |
29,344
-6,817
| -19% | -$188K | 0.07% | 130 |
|
|
2024
Q1 | $1M | Sell |
36,161
-1,321
| -4% | -$36.7K | 0.08% | 118 |
|
|
2023
Q4 | $1.08M | Buy |
37,482
+1,171
| +3% | +$35.4K | 0.1% | 107 |
|
|
2023
Q3 | $1.2M | Sell |
36,311
-3,471
| -9% | -$123K | 0.13% | 95 |
|
|
2023
Q2 | $1.46M | Buy |
39,782
+348
| +0.9% | +$13.5K | 0.16% | 90 |
|
|
2023
Q1 | $1.61M | Sell |
39,434
-660
| -2% | -$28.5K | 0.18% | 70 |
|
|
2022
Q4 | $2.05M | Sell |
40,094
-808
| -2% | -$38.7K | 0.24% | 60 |
|
|
2022
Q3 | $1.79M | Sell |
40,902
-2,694
| -6% | -$131K | 0.25% | 49 |
|
|
2022
Q2 | $2.29M | Buy |
43,596
+880
| +2% | +$44.8K | 0.31% | 49 |
|
|
2022
Q1 | $2.21M | Sell |
42,716
-1,170
| -3% | -$60.7K | 0.26% | 51 |
|
|
2021
Q4 | $2.59M | Sell |
43,886
-3,711
| -8% | -$184K | 0.31% | 49 |
|
|
2021
Q3 | $2.05M | Sell |
47,597
-43,650
| -48% | -$1.93M | 0.27% | 52 |
|
|
2021
Q2 | $3.57M | Sell |
91,247
-39,467
| -30% | -$1.53M | 0.48% | 47 |
|
|
2021
Q1 | $4.74M | Buy |
130,714
+10,296
| +9% | +$366K | 0.67% | 39 |
|
|
2020
Q4 | $4.43M | Buy |
120,418
+9,934
| +9% | +$364K | 0.66% | 36 |
|
|
2020
Q3 | $3.85M | Buy |
110,484
+3,367
| +3% | +$118K | 0.64% | 40 |
|
|
2020
Q2 | $3.91M | Buy |
107,117
+12,590
| +13% | +$428K | 0.66% | 39 |
|
|
2020
Q1 | $2.93M | Buy |
94,527
+4,735
| +5% | +$161K | 0.66% | 37 |
|
|
2019
Q4 | $3.34M | Buy |
89,792
+4,738
| +6% | +$169K | 0.56% | 47 |
|
|
2019
Q3 | $2.9M | Buy |
85,054
+3,500
| +4% | +$127K | 0.54% | 48 |
|
|
2019
Q2 | $3.35M | Buy |
81,554
+4,961
| +6% | +$197K | 0.66% | 40 |
|
|
2019
Q1 | $3.09M | Buy |
76,593
+15,175
| +25% | +$608K | 0.66% | 35 |
|
|
2018
Q4 | $2.54M | Sell |
61,418
-697
| -1% | -$28.9K | 0.57% | 29 |
|
|
2018
Q3 | $2.6M | Buy |
62,115
+6,917
| +13% | +$266K | 0.63% | 24 |
|
|
2018
Q2 | $1.9M | Buy |
55,198
+97
| +0.2% | +$3.31K | 0.49% | 29 |
|
|
2018
Q1 | $1.85M | Sell |
55,101
-233
| -0.4% | -$8.01K | 0.46% | 26 |
|
|
2017
Q4 | $1.9M | Buy |
55,334
+5,295
| +11% | +$181K | 0.46% | 29 |
|
|
2017
Q3 | $1.7M | Sell |
50,039
-2,871
| -5% | -$92.3K | 0.51% | 23 |
|
|
2017
Q2 | $1.69M | Buy |
52,910
+1,191
| +2% | +$37.6K | 0.51% | 24 |
|
|
2017
Q1 | $1.68M | Buy |
51,719
+2,995
| +6% | +$94.4K | 0.53% | 24 |
|
|
2016
Q4 | $1.5M | Buy |
48,724
+3,773
| +8% | +$115K | 0.5% | 29 |
|
|
2016
Q3 | $1.44M | Buy |
44,951
+2,080
| +5% | +$69.5K | 0.52% | 23 |
|
|
2016
Q2 | $1.43M | Buy |
42,871
+711
| +2% | +$22.7K | 0.54% | 19 |
|
|
2016
Q1 | $1.19M | Sell |
42,160
-579
| -1% | -$16.5K | 0.47% | 31 |
|
|
2015
Q4 | $1.31M | Buy |
42,739
+798
| +2% | +$25.1K | 0.5% | 27 |
|
|
2015
Q3 | $1.25M | Sell |
41,941
-75
| -0.2% | -$2.4K | 0.49% | 27 |
|
|
2015
Q2 | $1.34M | Sell |
42,016
-164
| -0.4% | -$5.34K | 0.55% | 16 |
|
|
2015
Q1 | $1.39M | Buy |
42,180
+527
| +1% | +$16.8K | 0.55% | 21 |
|
|
2014
Q4 | $1.23M | Sell |
41,653
-86
| -0.2% | -$2.47K | 1.04% | 24 |
|
|
2014
Q3 | $1.17M | Buy |
41,739
+342
| +0.8% | +$9.6K | 0.91% | 25 |
|
|
2014
Q2 | $1.17M | Buy |
41,397
+1,617
| +4% | +$46.1K | 1.03% | 23 |
|
|
2014
Q1 | $1.21M | Buy |
39,780
+474
| +1% | +$14.1K | 1.25% | 16 |
|
|
2013
Q4 | $1.14M | Buy |
+39,306
| New | +$1.14M | 1.02% | 20 |
|
Other funds holding PFE
AIM
CWP
DADC
WG
Fragasso Financial Advisors's PFE Position: Q2 2026 in Review
Fragasso Financial Advisors reduced its Pfizer (PFE) stake by 3.4% in Q2 2026, selling an estimated $20.4K and leaving 22,006 shares worth $530K. The position accounts for 0.03% of the portfolio, ranked #213.
Fragasso Financial Advisors first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $4.74M in Q1 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Fragasso Financial Advisors held 22,006 shares of Pfizer worth $530K as of Q2 2026.
- Fragasso Financial Advisors sold 780 Pfizer shares in Q2 2026, an estimated $20.4K.
- Pfizer made up 0.03% of Fragasso Financial Advisors's portfolio in Q2 2026, its #213 holding.
- Fragasso Financial Advisors first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
- Fragasso Financial Advisors's Pfizer position peaked at $4.74M in Q1 2021.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Fragasso Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.